ISCHAEMIC ACUTE RENAL FAILURE AND AGE: MODULATION BY ANTI-INFLAMMATORY EMBRYONIC STEM CELL-DERIVED MACROPHAGES
缺血性急性肾衰竭和年龄:抗炎胚胎干细胞源性巨噬细胞的调节
基本信息
- 批准号:G0801235/1
- 负责人:
- 金额:$ 57.33万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2009
- 资助国家:英国
- 起止时间:2009 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Renal ischaemia-reperfusion injury follows the restoration of blood flow to kidneys starved of blood following a prolonged lowering of blood pressure caused, for example, by severe infection or trauma. The kidney is infiltrated with white blood cells such as macrophages and many kidney cells die resulting in acute renal failure and the requirement for dialysis. Elderly individuals are more vulnerable to developing acute renal failure as a complication of other illnesses and have a worse outcome compared to younger individuals. This proposal will use state-of-the-art embryonic stem cell technology together with genetic and pharmacological manipulation to generate significant numbers of macrophages that express the anti-inflammatory enzyme hemeoxygenase-1. The nature of these embryonic stem cell-derived macrophages will be scrutinised in cell culture and they will then be administered to mice with ischaemia-reperfusion injury as ?cell therapy? with the prediction that they will significantly protect kidney function. The effect of macrophage cell therapy will be specifically examined in old mice that develop worse renal failure than young mice following a period of diminished blood flow to the kidney. This work will lay the foundation for further studies utilising the potential anti-inflammatory and reparative properties of embryonic stem cell-derived ?designer? macrophages.
肾缺血-再灌注损伤是在例如由严重感染或创伤引起的血压长期降低后,血流恢复到缺乏血液的肾脏。肾脏被白色血细胞如巨噬细胞浸润,许多肾细胞死亡,导致急性肾衰竭和需要透析。老年人更容易发生急性肾衰竭作为其他疾病的并发症,并且与年轻人相比结局更差。该提案将使用最先进的胚胎干细胞技术以及遗传和药理学操作来产生大量表达抗炎酶血红素加氧酶-1的巨噬细胞。这些胚胎干细胞衍生的巨噬细胞的性质将在细胞培养中进行仔细检查,然后将它们用于缺血再灌注损伤的小鼠。细胞疗法预测它们将显著保护肾功能。巨噬细胞治疗的效果将在老年小鼠中进行具体检查,老年小鼠在肾脏血流减少一段时间后发生比年轻小鼠更严重的肾衰竭。这项工作将奠定基础,进一步研究利用潜在的抗炎和修复特性的胚胎干细胞衍生的?设计师?巨噬细胞
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeremy Hughes其他文献
Urinary Clusterin is a Biomarker of Renal Epithelial Senescence and Predicts Human Kidney Disease Progression
尿簇集素是肾上皮衰老的生物标志物并可预测人类肾脏疾病进展
- DOI:
10.1016/j.ekir.2025.04.035 - 发表时间:
2025-07-01 - 期刊:
- 影响因子:5.700
- 作者:
David P. Baird;Maximilian Reck;Ross Campbell;Marie-Helena Docherty;Piotr P. Janas;Tilly Mason;Zenuida Mortuza;Matthieu Vermeren;Andy Nam;Wei Yang;Nathan Schurman;Claire Williams;Jamie P. Traynor;Patrick B. Mark;Katie J. Mylonas;Jeremy Hughes;Laura Denby;Bryan R. Conway;David A. Ferenbach - 通讯作者:
David A. Ferenbach
Hablamos Español: Insights from Three Web Designers Who Design a Bilingual or Multilingual Websites that Target Hispanic Audiences
Hablamos Español:三位网页设计师的见解,他们设计了针对西班牙裔受众的双语或多语言网站
- DOI:
- 发表时间:
2007 - 期刊:
- 影响因子:0
- 作者:
Jeremy Hughes - 通讯作者:
Jeremy Hughes
Pericytes in the renal vasculature: roles in health and disease
肾血管中的周细胞:在健康和疾病中的作用
- DOI:
10.1038/s41581-018-0032-4 - 发表时间:
2018-06-25 - 期刊:
- 影响因子:39.800
- 作者:
Isaac Shaw;Sebastien Rider;John Mullins;Jeremy Hughes;Bruno Péault - 通讯作者:
Bruno Péault
A History of Ancient Israel and Judah
古代以色列和犹大的历史
- DOI:
10.18647/1515/jjs-1990 - 发表时间:
1990 - 期刊:
- 影响因子:0
- 作者:
Jeremy Hughes - 通讯作者:
Jeremy Hughes
Modeling loan losses a macroeconomic approach 2013
使用宏观经济方法对贷款损失进行建模 2013
- DOI:
- 发表时间:
2018 - 期刊:
- 影响因子:0
- 作者:
Jeremy Hughes - 通讯作者:
Jeremy Hughes
Jeremy Hughes的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeremy Hughes', 18)}}的其他基金
MACROPHAGE EMIGRATION FROM THE INFLAMED KIDNEY INTERSTITIUM: REGULATION BY APOPTOTIC CELLS
巨噬细胞从发炎的肾间质中迁移:凋亡细胞的调节
- 批准号:
G0700330/1 - 财政年份:2008
- 资助金额:
$ 57.33万 - 项目类别:
Research Grant
相似海外基金
Artificial Intelligence to Predict Outcomes in Patients with Acute Kidney Injury on Continuous Renal Replacement Therapy
人工智能预测急性肾损伤患者连续肾脏替代治疗的结果
- 批准号:
10658576 - 财政年份:2023
- 资助金额:
$ 57.33万 - 项目类别:
lmmunomodulatory roles of renal lymphatic endothelial cells in Acute Kidney Injury
肾淋巴内皮细胞在急性肾损伤中的免疫调节作用
- 批准号:
10612171 - 财政年份:2023
- 资助金额:
$ 57.33万 - 项目类别:
Investigation of the association between acute graft-versus-host disease and renal impairment.
急性移植物抗宿主病与肾功能损害之间关系的调查。
- 批准号:
23K19558 - 财政年份:2023
- 资助金额:
$ 57.33万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of a remote physical activity management program specifically designed to protect renal function in patients with acute coronary syndrome
开发专门用于保护急性冠脉综合征患者肾功能的远程体力活动管理程序
- 批准号:
23K19837 - 财政年份:2023
- 资助金额:
$ 57.33万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility
肝硬化患者肾脏健康的新型生物标志物对急性肾损伤发生风险和可逆性的分层
- 批准号:
10675684 - 财政年份:2022
- 资助金额:
$ 57.33万 - 项目类别:
Application of Novel Biomarkers of Renal Health in Cirrhosis Patients to Stratify Risk of Acute Kidney Injury Occurrence and Reversibility
肝硬化患者肾脏健康的新型生物标志物对急性肾损伤发生风险和可逆性的分层
- 批准号:
10525756 - 财政年份:2022
- 资助金额:
$ 57.33万 - 项目类别:
Elucidation of the mechanism of exercise-induced acute kidney injury associated with renal hypouricemia type 1 model mice
肾性低尿酸血症1型模型小鼠运动性急性肾损伤机制的阐明
- 批准号:
22K08320 - 财政年份:2022
- 资助金额:
$ 57.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AI driven acute renal replacement therapy - (AID-ART)
AI 驱动的急性肾脏替代疗法 - (AID-ART)
- 批准号:
10630230 - 财政年份:2021
- 资助金额:
$ 57.33万 - 项目类别:
Improving perioperative management to reduce postoperative acute kidney injury and long-term renal risk
改善围手术期管理以减少术后急性肾损伤和长期肾脏风险
- 批准号:
10475332 - 财政年份:2021
- 资助金额:
$ 57.33万 - 项目类别:
AI driven acute renal replacement therapy - (AID-ART)
AI 驱动的急性肾脏替代疗法 - (AID-ART)
- 批准号:
10371943 - 财政年份:2021
- 资助金额:
$ 57.33万 - 项目类别: